A study to investigate the effects of nebulised magnesium in severe exacerbations of asthma

• Conditions: Acute asthma; Respiratory - Asthma

• Registration Number: ACTRN12609000038291
• Lead Sponsor: Medical Research Institute of New Zealand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-01-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Aged between 16 and 65 years; Doctor diagnosis of asthma; Presentation to the Emergency Department (ED) with a severe exacerbation of asthma (initial FEV1 < or = 50% predicted)

Exclusion Criteria

Patients requiring intubation or too unwell to perform spirometry on at presentation; Known cardiac disease, chronic renal insufficiency or another serious medical condition that would prevent their participation in the trial; Pregnant women; Pneumothorax or pneumonia; Previously documented chronic airflow limitation with fixed airways obstruction.

Study & Design

• Study Type: Interventional
• Study Design: Not specified